Update on lung cancer biology for clinicians
Symposium Chairs: P. Schnabel (Meckesheim, Germany), S. Spiro (Middlesex, United Kingdom)
Aims: The audience will get an update on the current developments of targeted therapy of lung cancer, the importance of molecular pathology for optimising tumour differentiation and therapy selection, and the challenges involved in useing newly developed strategies.